The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the...
Laboratory Innovation: Dr. Bill Morice - Insights
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
New Strategies to Combat COVID-19: Dr. Bill Morice - Insights
This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
Lab developed tests: Dr. Bill Morice - Insights
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
Understanding the difference between benign and malignant adrenal tumors has alway been difficult; this new assay will assist with this medical challenge.
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.
Autoimmune Movement Disorders - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune movement disorders contain clinically relevant antibodies providing accurate answers for treatment guidance.
Neurogenetic Testing - Mayo Clinic Laboratories
We offer comprehensive neurogenetic testing, backed by a multidisciplinary team of clinical neurology experts, laboratory scientists, and genetic counselors, to provide the highest standard for mutation detection and depth of coverage.
Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.
Genetics - Mayo Clinic Laboratories
Our genetic testing was developed by experienced geneticists, genetic counselors, laboratory scientists, and bioinformaticians. We focus on providing easy to understand answers, interpreted by those same individuals who have an intimate...